GLORIA DOWNEY: Open Payments
NPI 1669456380 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,506 in 167 payments from 11 companies in 2025. Trend: 2023 $3,249 · 2024 $3,373 · 2025 $3,506
Food & beverage: $3,412Education: $95
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 73 | $1,238 |
| E.R. Squibb & Sons, L.L.C. | 12 | $330 |
| Alkermes, Inc. | 16 | $330 |
| Vanda Pharmaceuticals Inc. | 11 | $325 |
| Otsuka America Pharmaceutical, Inc. | 9 | $266 |
| Janssen Pharmaceuticals, Inc | 11 | $241 |
| Lundbeck LLC | 10 | $212 |
| Neurocrine BioSciences, Inc. | 8 | $190 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $181 |
| Axsome Therapeutics, Inc. | 5 | $109 |
Products named: UZEDY, AUSTEDO XR, COBENFY, FANAPT, ARISTADA, INVEGA SUSTENNA, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across GA — which companies pay providers there.
